Bit & Bridle

Equine Bone Spavin

Other Names

  • Jack Spavin (significant bony enlargement)
  • High Spavin (pathology higher in the joint)
  • Occult Spavin (no visible bony enlargement)
  • Blood Spavin (superficial vein involvement)
  • Hock Osteoarthritis
  • Distal Tarsal Osteoarthritis

What Is Equine Bone Spavin?

Bone spavin is one of the most common causes of hindlimb lameness in horses. It is a degenerative joint condition affecting the distal (lower) joints of the hock — most commonly the distal intertarsal and tarsometatarsal joints, and less frequently the proximal intertarsal joint. The condition involves progressive osteoarthritis of these small, low-motion joints, often accompanied by periarticular new bone formation (osteophytes) that can become visible and palpable as a bony enlargement on the inner (medial) aspect of the lower hock.

The name “bone spavin” reflects the historical observation of a bony lump on the inside of the hock, though it is important to understand that the outward bony change is a consequence of the underlying joint disease, not the disease itself. Some horses have significant joint pathology and lameness without visible external swelling — these are classified as occult spavin and can be particularly challenging to diagnose.

Bone spavin is most prevalent in draught breeds and warmbloods, though it can affect horses of any breed and age. Performance horses in disciplines that demand repeated hock flexion — dressage, show jumping, eventing, driving — are at particular risk. The condition is progressive, but many horses can remain comfortable and working with appropriate management.

Causes

Bone spavin is fundamentally a disease of wear-and-tear on the small hock joints, but several factors accelerate its development:

  • Conformation: Poor hind limb conformation — including sickle hocks (excessive forward angulation), cow hocks (inward deviation at the hocks), and straight hocks — places abnormal mechanical load on the distal tarsal joints and significantly increases the risk of degenerative joint disease.
  • Breed predisposition: Draught breeds (including Irish Drafts), Icelandic horses, warmbloods, and some pony breeds have higher reported incidence, suggesting a heritable component to susceptibility.
  • Age: The condition is predominantly a disease of mature horses, though it can occasionally present in younger horses in high-intensity training.
  • Work intensity: High-impact, repetitive work — particularly on hard surfaces — increases wear on joint cartilage and accelerates degenerative change. Horses working on consistently hard ground without adequate hoof preparation and shoeing are at elevated risk.
  • Nutritional factors: Imbalanced calcium-phosphorus ratios during growth, and diets deficient in key minerals, may predispose horses to suboptimal bone and cartilage development.
  • Previous trauma: Injury to the hock joint, tarsal fractures, or osteochondrosis (OCD) lesions in the hock may predispose to early-onset osteoarthritis.

Symptoms and Signs

Clinical signs of bone spavin range from subtle to severe and typically have a gradual onset:

  • Hindlimb lameness: Often bilateral (affecting both hind legs), which can make it difficult to detect on a straight line. Lameness is typically worse when the horse is worked on a circle, particularly on hard ground, or when asked to collect or work in self-carriage.
  • Stiffness at the start of work: Many horses with bone spavin show marked stiffness for the first 10–20 minutes of exercise that gradually improves as the joints warm up. This “warming out of lameness” is a classic hallmark of distal hock joint disease.
  • Shortened hindlimb stride: Reduced hock flexion results in a choppy, restricted gait behind, with the horse appearing to drag its hind feet or lack engagement through the hindquarters.
  • Bony swelling: A firm, non-painful bony prominence on the lower inner aspect of the hock. This may be visible and palpable, or absent in cases of occult spavin.
  • Positive spavin test: When the hock is held in maximum flexion for 60–90 seconds and the horse is immediately trotted away, an exacerbation of lameness is considered a positive response and is highly suggestive of distal hock joint disease.
  • Muscle atrophy: In chronic cases, loss of muscle mass over the hindquarters — particularly the gluteal muscles — may become apparent due to reduced use and altered gait mechanics.

Diagnosis

Definitive diagnosis requires a systematic approach combining clinical examination and diagnostic imaging:

  • Lameness examination: Thorough dynamic assessment at walk and trot, in hand and under saddle, on straight lines and circles, with and without flexion tests.
  • Perineural and intra-articular nerve blocks: Local anaesthetic injections into specific hock joints — most valuably the distal intertarsal and tarsometatarsal joints — confirm the location of pain when blocking these joints abolishes or significantly reduces the lameness.
  • Radiography: X-rays of the hock are the primary imaging modality and typically demonstrate periarticular osteophytes, joint space narrowing, and subchondral bone changes in the distal tarsal joints. Occult spavin cases may show only subtle radiographic changes.
  • Nuclear scintigraphy: Bone scanning is particularly useful for detecting early or occult spavin where radiographic changes are minimal, as it identifies areas of increased bone remodelling activity.
  • MRI and CT: Advanced imaging modalities that provide detailed assessment of both bony and soft tissue structures — increasingly available and valuable in complex or early-onset cases.

Treatment

Treatment aims to manage pain and maintain function. Options span conservative management through to surgical intervention:

  • Intra-articular corticosteroids: Injections of corticosteroid (with or without hyaluronic acid) into the affected joints provide effective pain relief and can significantly reduce lameness in many horses. Effects typically last two to six months, and injections can be repeated.
  • Systemic anti-inflammatory medication: Non-steroidal anti-inflammatory drugs (NSAIDs) such as phenylbutazone (“bute”) provide systemic pain relief during acute flare-ups and for horses in ongoing work. Long-term NSAID use requires careful monitoring for gastrointestinal and renal side effects.
  • Therapeutic shoeing: Farriery plays a significant role in managing bone spavin. Rolled or rocker-toed shoes reduce the range of hock motion during break-over and ease the joint. Raised heel shoes may reduce stress on specific tarsal joints. A close working relationship between vet and farrier is important.
  • Bisphosphonates: Tiludronate and clodronate work by modifying bone remodelling processes. In the UK, tiludronate (Tildren) is licensed as an aid in the treatment of lameness associated with bone spavin, in horses over 3. Clodronate (Osphos) is licensed for forelimb lameness associated with bone resorption in the navicular bone, not for bone spavin, and not in horses under 4 (VMD datasheets). They provide medium-term pain relief in a significant proportion of cases and may be particularly beneficial in horses with ongoing active bone remodelling.
  • Exercise management: Consistent, moderate exercise on good surfaces is generally preferable to erratic work patterns. Turnout on soft ground is beneficial. Avoid sustained work on hard ground and excessive collection work during flare-ups.
  • Surgical arthrodesis: In cases refractory to conservative management, surgical fusion of the distal tarsal joints — either by chemical arthrodesis (injection of ethanol or sodium monoiodoacetate into the joint to induce controlled fusion) or mechanical arthrodesis (drilling, placement of screws) — can provide permanent pain relief once fusion is complete. Surgical arthrodesis is appropriate only for the low-motion distal joints of the hock; the true hock joint (tibiotarsal joint) must not be fused.

For guidance on hock health and shoeing, the BEVA provides veterinary resources on degenerative joint disease management.

Prevention

Whilst bone spavin cannot always be prevented, the following reduce risk and slow progression:

  • Select breeding stock with good hind limb conformation — avoid propagating sickle hocks, cow hocks, and excessively straight hocks.
  • Ensure appropriate farriery and foot balance from a young age. Unbalanced feet place abnormal load through the hock joints.
  • Introduce young horses to work gradually and avoid placing heavy demands on developing joints before skeletal maturity (typically five years of age for most breeds).
  • Provide consistent footing for work and training — avoid prolonged work on very hard or very deep surfaces.
  • Support joint health with appropriate nutrition throughout the horse’s life.

See our articles on Equine Bog Spavin and the horse’s hock joint for further reading on hock conditions.

Prognosis

Bone spavin is a manageable condition for the majority of horses, though it cannot be cured. Many horses continue in work for years with appropriate treatment, shoeing, and exercise management. Those with severe articular destruction, bilateral disease affecting the true hock joint, or horses that fail to respond to conservative management have a more guarded prognosis. Horses that achieve successful surgical arthrodesis of the distal tarsal joints often return to full athletic use once fusion is complete, typically within 6–18 months post-procedure.

When to Call the Vet

Arrange a veterinary examination if you observe:

  • Progressive hindlimb lameness or stiffness, particularly at the start of exercise
  • A firm swelling on the lower inner aspect of one or both hocks
  • Reduced hindlimb engagement or shortened stride behind
  • A horse that has lost topline muscle over the hindquarters without an obvious cause
  • Any horse in work that shows a marked positive response to hock flexion tests

Frequently Asked Questions

Can a horse with bone spavin continue working?

Yes, many horses with bone spavin continue in full work for years with appropriate management. The key is matching the horse’s workload to its comfort level, optimising shoeing, and managing pain effectively. Work on soft, forgiving surfaces is preferable to hard ground. Regular veterinary review helps adjust the management plan as the condition evolves.

What is the difference between bone spavin and bog spavin?

Bone spavin involves degenerative joint disease of the distal hock joints with associated bony changes and lameness. Bog spavin is a distension of the joint capsule of the true hock (tibiotarsal) joint, appearing as a soft fluid-filled swelling at the front of the hock. Bog spavin may or may not cause lameness. The two conditions can coexist but are distinct disease processes. See our article on Equine Bog Spavin for more.

How long do hock injections last for bone spavin?

The duration of response to intra-articular corticosteroid injections varies between horses and with the severity of the disease. Most horses experience relief for two to six months. Some horses require injections every few months to maintain comfort; others respond for longer periods. Repeat injections are generally safe at intervals recommended by your vet, though frequent injections (more than two to three per year into the same joint) warrant careful monitoring.

Is bone spavin hereditary?

There is evidence of breed predisposition suggesting a heritable component to susceptibility, particularly in Icelandic horses and certain draught breeds. However, conformation, work intensity, and management also play major roles. Horses with poor hind limb conformation that predisposes to bone spavin should be considered carefully as breeding candidates.